Cannabis Insurance Access: Coverage Gaps, the CLAIM Act, and Federal Barriers
This hub explains why cannabis businesses struggle to obtain mainstream insurance and what is changing. It covers the federal-state legal conflict that keeps many large carriers out of the market, the reliance on surplus lines insurers, and the common coverage types operators need, including property, general liability, product liability, crop, and workers' compensation. It also tracks federal proposals such as the CLAIM Act, which targets the same conflict as SAFE Banking, and considers how rescheduling does or does not resolve the underlying problem. Operators, investors, and policy watchers will find practical context and links to related state and legislative coverage.

Executive summary
Cannabis insurance access is a federal-state conflict problem that rescheduling alone does not solve, and Congress is now being asked to fix it directly. State-licensed cannabis businesses can buy insurance, but mostly from a thin layer of surplus lines and specialty carriers. Most mainstream insurers stay out.
On September 23, 2026, MJBizDaily reported that mainstream insurance companies are pushing for access to the cannabis industry. The outlet framed the CLAIM Act as targeting the same federal-state conflict as SAFE Banking, and said that conflict keeps insurers out even after rescheduling. This hub treats that framing as its starting point. CannIntel has not independently verified the bill's text, so check the current bill on Congress.gov.
The core legal logic is simple. Marijuana remains a controlled substance under the Controlled Substances Act, 21 U.S.C. § 812. Moving it to Schedule III would change its penalties and tax treatment. It would not make state-licensed sales lawful under federal law. Insurers that pay claims for cannabis operations worry about aiding-and-abetting, conspiracy and money-laundering exposure. They also worry about how regulators, rating agencies and reinsurers will treat that exposure.
The practical result for operators is a market defined by:
- Higher premiums and tighter exclusions than comparable non-cannabis risks.
- Limited capacity for large multistate operators (MSOs).
- Coverage gaps in lines such as crop, product recall and directors and officers (D&O) liability.
- Heavy reliance on brokers who specialize in the sector.
This page covers the history, the legal framework, the state landscape, the business implications and the decision points ahead.
Why this matters
Insurance is the quiet infrastructure of commerce: leases, loans, licenses and payroll all depend on it, so gaps in coverage throttle the whole cannabis supply chain.
Insurance is a gating requirement for many ordinary business activities. Landlords require certificates of insurance before signing leases. Lenders require property coverage on collateral. State regulators in many licensing regimes require licensees to carry liability coverage. Nearly every state requires employers to carry workers' compensation. A cannabis operator that cannot buy coverage often cannot open, finance or stay open.
Who is affected
- Cultivators and manufacturers: They face fire, equipment breakdown, crop loss, contamination and product liability exposures. Extraction operations with flammable solvents are among the hardest risks to place.
- Retailers and delivery operators: They need property, general liability, theft, cash-in-transit and commercial auto coverage. Delivery adds vehicle and cargo risk.
- Ancillary businesses: Packaging, software, testing labs and consultants often cannot tell whether their carrier will treat them as "touching the plant."
- Employees: Workers' compensation determines whether injured workers get paid reliably.
- Patients and consumers: Product liability coverage is the financial backstop when a contaminated or mislabeled product causes harm. Thin coverage can leave injured consumers with weaker recourse.
- Insurers themselves: The sector is a growth market for carriers willing to underwrite it, and a reputational and legal question for those that are not.
The CannIntel lens: three gates
CannIntel's working framework is that mainstream carriers must pass three gates before writing cannabis business at scale:
- Legal gate: Can the carrier pay claims without creating federal criminal or civil exposure?
- Regulatory and rating gate: Will state insurance departments, rating agencies and holding-company regulators accept the risk on an admitted basis?
- Capacity gate: Will reinsurers back the risk, and at what price?
Rescheduling plausibly loosens the third gate more than the first. Legislation like the CLAIM Act, as MJBizDaily describes it, aims at the first. That is why the "after rescheduling" framing matters.
Background and history
Cannabis insurance has evolved over a decade from a handful of improvised specialty programs into a niche but functioning surplus lines market, with each federal policy shift moving carrier appetite.
1970: The Controlled Substances Act sets the conflict
Congress enacted the Controlled Substances Act in 1970 and placed marijuana in Schedule I. Under 21 U.S.C. § 812, Schedule I status means a high potential for abuse and no accepted medical use. Every later insurance problem traces to that classification. Related provisions include 21 U.S.C. § 856 (maintaining drug-involved premises) and 21 U.S.C. § 846 (conspiracy).
1996–2012: State programs begin
California voters approved Proposition 215 in 1996, creating the first modern medical cannabis program. Other states followed. Insurance in this era was ad hoc. Many operators were uninsured or relied on personal policies that did not contemplate commercial cannabis activity. In 2012, Colorado and Washington voters approved adult-use legalization, creating regulated markets with real assets, real payrolls and real liabilities.
2013–2014: The Cole Memo and FinCEN guidance
The Department of Justice issued the Cole Memo on August 29, 2013. It signaled that federal prosecutors would generally defer to well-regulated state systems. In February 2014, FinCEN issued guidance on Bank Secrecy Act expectations for banks serving marijuana-related businesses. Neither document changed federal law. Both gave financial institutions, including some insurers, a working framework for engagement.
In December 2014, Congress passed the first appropriations rider, known as Rohrabacher-Farr and later Blumenauer-Joyce-Aderholt-style language. It barred DOJ from using funds to interfere with state medical cannabis programs. Congress has renewed it in later appropriations cycles.
2015–2017: Specialty carriers and brokers emerge
As state markets grew, specialty brokers and surplus lines carriers built cannabis programs. The surplus lines market suits this risk because it allows underwriting of risks that admitted carriers decline, usually with less rate and form regulation. Coverage was typically more expensive and narrower than conventional commercial policies. Underwriters scrutinized security, solvent handling and electrical systems closely.
2018: The Cole Memo is rescinded and hemp is legalized
In January 2018, Attorney General Jeff Sessions rescinded the Cole Memo. The rescission raised short-term uncertainty for financial institutions, though large-scale federal enforcement against state-compliant operators did not follow. In December 2018, the Farm Bill removed hemp with no more than 0.3% delta-9 THC from the CSA definition of marijuana. That opened a lawful federal path for hemp and CBD insurance, though hemp coverage still has its own gaps.
2019–2023: SAFE Banking moves, then stalls
The House passed the SAFE Banking Act on September 25, 2019, by a vote of 321-103. It passed again in April 2021, 321-101. Congress did not enact it. The Senate version, the SAFER Banking Act, cleared the Senate Banking Committee 14-9 on September 27, 2023, but did not reach a floor vote.
Banking and insurance are parallel problems. Both involve regulated financial institutions that fear federal exposure for serving state-licensed businesses. Banking drew far more legislative attention. Insurance advocates have argued that access to coverage deserves its own fix.
2023–2025: Rescheduling begins
In August 2023, HHS recommended moving marijuana to Schedule III. In May 2024, the DEA published a Notice of Proposed Rulemaking (NPRM) to do so. An administrative hearing before an Administrative Law Judge (ALJ) was scheduled for January 2025, but proceedings were stayed amid litigation and the change in administration. In December 2025, President Trump signed an executive order directing the Attorney General to expedite rescheduling to Schedule III.
2025–2026: Hemp redefinition and the CLAIM Act push
In November 2025, Congress enacted a spending law that redefines hemp to restrict many intoxicating hemp-derived products, with a delayed effective date in late 2026. It adds a compliance deadline for hemp businesses and their insurers. On September 23, 2026, MJBizDaily reported on mainstream insurers pushing for cannabis access and described the CLAIM Act as targeting the federal-state conflict that rescheduling does not resolve.
Key players
Cannabis insurance policy is shaped by a small set of agencies, trade groups, carriers and lawmakers, each with different incentives.
Congress
Congress controls the fix. SAFE Banking and SAFER Banking showed that bipartisan majorities can form around financial-access bills. They also showed how easily such bills stall. The CLAIM Act, as MJBizDaily describes it, seeks the same kind of safe harbor for insurers. Check Congress.gov for sponsors, text and committee referral.
DEA and the Department of Justice
The DEA administers scheduling. DOJ sets prosecutorial priorities. A Schedule III final rule would reshape tax and research rules. It would not by itself authorize state-licensed commercial sales under the CSA.
FDA and HHS
The FDA conducted the eight-factor analysis that fed HHS's 2023 recommendation. In a Schedule III world, the FDA's drug approval framework remains relevant to whether state-licensed products can be considered lawful federally. That question underlies insurer legal risk.
State insurance departments and the NAIC
State insurance departments license carriers, approve forms and rates for admitted business, and regulate surplus lines placement. The National Association of Insurance Commissioners (NAIC) coordinates model laws and discussion among them. Insurance is regulated primarily at the state level, so department posture shapes how comfortable carriers feel.
Surplus lines carriers and specialty brokers
Surplus lines carriers, including Lloyd's market participants, provide most commercial cannabis coverage. Specialty brokers package policies and educate underwriters. Their business depends on the current gap, and their expertise would remain valuable even if mainstream carriers enter.
Mainstream insurers
Large admitted carriers hold balance sheet capacity that the surplus market lacks. MJBizDaily's report says they are pushing for access. Their entry would likely lower prices for low-hazard risks first, such as retail property and general liability.
Industry advocates
Trade groups such as the National Cannabis Industry Association have long lobbied for banking and financial-services fixes. Insurance is a natural extension. Opposition to financial-access bills generally comes from lawmakers and advocates who oppose cannabis legalization, or who want broader reforms to accompany access.
Legal and regulatory framework
Insurers face a layered legal risk: federal criminal statutes, state insurance law and the contractual doctrine that illegal contracts may be unenforceable.
Federal statutes
- 21 U.S.C. § 812: Schedule I classification of marijuana.
- 21 U.S.C. § 846: Conspiracy to commit a CSA offense.
- 21 U.S.C. § 856: Maintaining places for drug manufacture, distribution or use.
- 18 U.S.C. § 2: Aiding and abetting.
- 18 U.S.C. §§ 1956 and 1957: Money laundering, relevant because premium and claim payments can involve proceeds of a CSA violation.
- 26 U.S.C. § 280E: Denies business deductions to trafficking in Schedule I and II substances, a major financial pressure on operators that compounds insurance costs. See 280E.
Why rescheduling does not solve the insurer problem
Schedule III substances can be lawfully distributed only through FDA-approved drug channels or DEA registration. State-licensed dispensaries are not operating within that system. A final Schedule III rule would likely end 280E treatment, because the section covers only Schedules I and II. It would not by itself provide a federal safe harbor for state-licensed commercial activity. That is the gap MJBizDaily says the CLAIM Act targets.
Federalism
The McCarran-Ferguson Act of 1945 leaves insurance regulation primarily to the states. That cuts two ways. States can encourage carrier participation through guidance and licensing posture. But states cannot immunize carriers from federal criminal law. A federal safe harbor would sit atop state regulation rather than replace it.
Contract enforceability
Courts have split on whether cannabis-related contracts are enforceable given federal illegality. Insurers worry that a policy could be attacked as void, or that a claim could be refused on public policy grounds. Conversely, some courts have required payment on claims in state-legal contexts. Operators should read policy language on illegal acts, "contraband" and "controlled substances" exclusions carefully.
Coverage lines
| Line | Typical cFrequently asked questionsWhy is it hard for cannabis businesses to get insurance?Cannabis remains subject to federal law even where states have legalized it. Many large, federally regulated carriers worry about legal exposure, reinsurance restrictions, and regulatory scrutiny, so they avoid the sector. That leaves operators with fewer options, narrower coverage, higher premiums, and heavier reliance on specialty insurers willing to underwrite the risk. What is the CLAIM Act?As reported by MJBizDaily in September 2026, the CLAIM Act is a federal proposal that, like SAFE Banking, targets the federal-state conflict keeping mainstream insurers out of cannabis. Its goal is to give insurers legal clarity to serve state-licensed businesses. Check the bill text and congressional records for current provisions and status. How is the CLAIM Act similar to SAFE Banking?Both approaches aim to protect financial-services providers that work with state-legal cannabis businesses. SAFE Banking focuses on banks and credit unions, while the CLAIM Act focuses on insurers. Each seeks to reduce the risk that federal law will penalize regulated institutions for serving licensed operators. Does rescheduling cannabis solve the insurance problem?Not necessarily. Moving cannabis to a less restrictive federal schedule would change how it is classified, but reporting from MJBizDaily indicates the federal-state conflict that deters insurers can persist even after rescheduling. Because state-licensed sales would still not be fully aligned with federal rules, carriers may keep seeing legal and regulatory uncertainty. What types of insurance do cannabis businesses typically need?Common coverages include commercial property, general liability, product liability, product recall, crop and cultivation coverage, workers' compensation, commercial auto, cyber liability, and directors and officers coverage. Needs vary by license type. Cultivators, manufacturers, dispensaries, and delivery operators each face different hazards such as fire, theft, contamination, and transport risk. What are surplus lines insurers, and why do cannabis companies use them?Surplus lines insurers are non-admitted carriers that cover risks the standard market declines. They can write customized policies with more flexible terms and are not bound by some state rate and form rules. Many cannabis operators use them because admitted carriers often avoid the industry, though coverage can be pricier and more restrictive. Can cannabis businesses get workers' compensation insurance?Yes, but options vary by state and by carrier appetite. In some states, operators can buy through the private market or state funds, while others may require specialty providers. Employers should confirm that policies cover cannabis-specific job duties and that classification codes match their actual operations. Why does limited insurance access matter for the industry?Insurance underpins leases, loans, vendor contracts, and licensing requirements. Gaps can leave businesses exposed to catastrophic loss, raise operating costs, and deter investors or landlords. Broader access could improve risk management, consumer protection, and the industry's ability to operate like other regulated sectors. Do state laws require cannabis businesses to carry insurance?Some states and localities require licensees to maintain certain coverage, such as general liability, as a condition of licensing. Requirements differ widely by jurisdiction and license type. Operators should review their state regulator's current rules and local ordinances before purchasing a policy. How can cannabis operators lower their insurance costs?Strong security, documented compliance, quality-control and recall procedures, employee training, and clean claims history can improve underwriting outcomes. Working with a broker experienced in cannabis helps match operators with appropriate carriers. Comparing quotes, deductibles, and exclusions also matters, since policy terms can differ significantly. cannabis insuranceCLAIM ActSAFE Bankingreschedulingcannabis regulationsurplus lines The CannIntel Daily The cannabis newsletter you forward to your team.Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free. No spam. Unsubscribe with one click. 21+ only. |
|---|